Vertex Pharmaceuticals Inc. buy Wells Fargo & Company
Start price
06.08.25
/
50%
€325.60
Target price
06.08.26
€397.62
Performance (%)
18.30%
Price
12.12.25
€385.20
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan currently has a performance of 18.30%. This prediction currently runs until 06.08.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | -1.509% | -1.509% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $460.00 price target on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€380.75
10.12.25
10.12.25
€442.18
10.12.26
10.12.26
1.17%
12.12.25
12.12.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€398.50
10.01.25
10.01.25
€447.72
10.01.26
10.01.26
-3.34%
12.12.25
12.12.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€439.95
24.06.24
24.06.24
€516.65
24.06.25
24.06.25
-11.44%
25.06.25
25.06.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€383.95
06.02.24
06.02.24
€502.09
06.02.25
06.02.25
21.15%
07.02.25
07.02.25